Christopher W. Fulton

Array ( [id] => 1575686 [patent_doc_number] => 06469138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Thrombospondin receptor binding peptides' [patent_app_type] => B1 [patent_app_number] => 08/391820 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 7092 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469138.pdf [firstpage_image] =>[orig_patent_app_number] => 08391820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871258 [patent_doc_number] => 05763395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Stabilized lanthionine bacteriocin compositions' [patent_app_type] => 1 [patent_app_number] => 8/386122 [patent_app_country] => US [patent_app_date] => 1995-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5449 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763395.pdf [firstpage_image] =>[orig_patent_app_number] => 386122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662883 [patent_doc_number] => 05648462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Peptide purification method using novel linker and solid-phase ligand' [patent_app_type] => 1 [patent_app_number] => 8/379039 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9371 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 312 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648462.pdf [firstpage_image] =>[orig_patent_app_number] => 379039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807709 [patent_doc_number] => 05831001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Treatment of herpesvirus infection' [patent_app_type] => 1 [patent_app_number] => 8/378709 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7514 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831001.pdf [firstpage_image] =>[orig_patent_app_number] => 378709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831550 [patent_doc_number] => 05739279 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents' [patent_app_type] => 1 [patent_app_number] => 8/373278 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7152 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739279.pdf [firstpage_image] =>[orig_patent_app_number] => 373278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328748 [patent_doc_number] => 06329502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => '.beta.-amino-.alpha.-hydroxycarboxylic acid derivatives and HIV protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/378057 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 53082 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329502.pdf [firstpage_image] =>[orig_patent_app_number] => 378057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3633692 [patent_doc_number] => 05610139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Antimicrobial compositions and pharmaceutical preparations thereof' [patent_app_type] => 1 [patent_app_number] => 8/375165 [patent_app_country] => US [patent_app_date] => 1995-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610139.pdf [firstpage_image] =>[orig_patent_app_number] => 375165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695636 [patent_doc_number] => 05679773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Reagants and methods for immobilized polymer synthesis and display' [patent_app_type] => 1 [patent_app_number] => 8/374492 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14767 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679773.pdf [firstpage_image] =>[orig_patent_app_number] => 374492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597172 [patent_doc_number] => 06492531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Method of treating cognitive disorders' [patent_app_type] => B1 [patent_app_number] => 08/372727 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19129 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 525 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492531.pdf [firstpage_image] =>[orig_patent_app_number] => 08372727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688779 [patent_doc_number] => 05663296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Hydroxamate inhibitors of endothelin converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/373911 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16135 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663296.pdf [firstpage_image] =>[orig_patent_app_number] => 373911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859743 [patent_doc_number] => 05705686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Inhibition of farnesyl transferase' [patent_app_type] => 1 [patent_app_number] => 8/371682 [patent_app_country] => US [patent_app_date] => 1995-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5180 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705686.pdf [firstpage_image] =>[orig_patent_app_number] => 371682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702310 [patent_doc_number] => 05674849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Anti-viral compositions' [patent_app_type] => 1 [patent_app_number] => 8/370545 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6769 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674849.pdf [firstpage_image] =>[orig_patent_app_number] => 370545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878403 [patent_doc_number] => 05804560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Peptide and peptide analog protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/369422 [patent_app_country] => US [patent_app_date] => 1995-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31268 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804560.pdf [firstpage_image] =>[orig_patent_app_number] => 369422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3852882 [patent_doc_number] => 05767235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Anticoagulant hirudin variants and methods for their production' [patent_app_type] => 1 [patent_app_number] => 8/367758 [patent_app_country] => US [patent_app_date] => 1995-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 15220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767235.pdf [firstpage_image] =>[orig_patent_app_number] => 367758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661628 [patent_doc_number] => 05624903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Phosphoinositol-glycan-peptide with insulin-like action' [patent_app_type] => 1 [patent_app_number] => 8/364398 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624903.pdf [firstpage_image] =>[orig_patent_app_number] => 364398 [rel_patent_id] =>[rel_patent_doc_number] =>)